Where does Centre Hospitalier Regional et Universitaire de Lille (CHRU) rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Centre Hospitalier Regional et Universitaire de Lille (CHRU) ranks #10,280 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Is Centre Hospitalier Regional et Universitaire de Lille (CHRU)'s patent grant rate increasing or decreasing?

Centre Hospitalier Regional et Universitaire de Lille (CHRU)'s recent grant velocity is +25% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Centre Hospitalier Regional et Universitaire de Lille (CHRU)'s patents?

Centre Hospitalier Regional et Universitaire de Lille (CHRU)'s patents average 12.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Centre Hospitalier Regional et Universitaire de Lille (CHRU)

Q: How is the Centre Hospitalier Regional et Universitaire de Lille (CHRU) patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 30 granted patents across 21 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Centre ranks #10,280 of 49,997 tracked US assignees by granted-patent volume, with 30 patents across 21 technology areas.

#10,280
of 49,997 US assignees by volume: Top 45%
by Innovation Score (37.1/100): 12.1
avg claims per patent: +25%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10280 · Foreign Corporation #10,280 · 30 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 30 grants
UPPER-Q #10,280/49,997
PHOTO-FINISH CamPlex
CPC-FOCUS A61P · 21 areas
INNOV-THIN 37.1/100
CLAIMS-RICH 12.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +25% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: CamPlex, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Centre’s 37.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.9 pts (32%) Velocity 1.8 pts (5%) Breadth 16.2 pts (44%) Claim depth 7.2 pts (19%)

Qualcomm Incorporated · highest

85
CBF Networks · near

37
Centre Hospitalier… · this assignee

37
Milgard Manufacturing · near

37
Noble International · near

37
Zerotech (SHENZHEN)… · near

37
3D Lighting… · lowest

7

What this shows Centre's Innovation Score is 37.1/100 (top 45% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Centre?

Each dot is one of Centre’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Centre’s own 12.1 claims/patent is at or below the 20.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Centre vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Centre's grants concentrate

Centre Hospitalier Regional et Universitaire de Lille (CHRU) is a focused PatentsView assignee: 21 CPC subclasses with 40% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (6 grants) versus a trough of 1 in 2015. By volume, Centre sits between CamPlex, Inc. and Chromalloy Gas Turbine LLC.

Centre's three-year grant acceleration

Centre Hospitalier Regional et Universitaire de Lille (CHRU) shows 4 grants in 2022–2024 against only 15 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Camplex

30
Candela

30
Carl Zeiss Multis…

30
Cellphone-mate

30
Chemimage

30
Chiaro Technology

30
Christian-albrech…

30
Chromalloy Gas Tu…

30
Centre Hospitalie… ◀

30

What this shows Centre holds 30 patents at rank #10,286, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Centre

By rank, the assignees closest to #10,286 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Centre's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Centre, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Centre ranks #1,593 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (37 here).

Noble International, Inc. 37 Milgard Manufacturing LLC 37 CBF Networks, Inc. 37 Zerotech (SHENZHEN) Intelligence Robot Co., Ltd. 37

Centre's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 45% higher than 55% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Centre Hospitalier Regional et Universitaire de Lille (CHRU) patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	3.3%
2016	1	3.3%
2017	3	10.0%
2018	3	10.0%
2019	4	13.3%
2020	6	20.0%
2021	5	16.7%
2023	4	13.3%
2025partial year	3	10.0%

Which technologies does Centre Hospitalier Regional et Universitaire de Lille (CHRU) patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 12

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 10

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 6

C07K - Peptides 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

A61B - DIAGNOSIS; SURGERY; Identification 4

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 4

Y02A - Technologies FOR Adaptation TO Climate Change 3

C07D - Heterocyclic Compounds 3

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 2

C07C - Acyclic OR Carbocyclic Compounds 2

Y10T - Technical Subjects Covered BY Former US Classification 1

G06T - Image Data Processing OR Generation, IN General 1

Top 15 of 21 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Centre Hospitalier Regional et Universitaire de Lille (CHRU)'s patent record in context - here's where to go next.

Centre Hospitalier Regional et Universitaire de Lille (CHRU)'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 40% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #10,280 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Centre Hospitalier Regional et Universitaire de Lille (CHRU) against CamPlex, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.